nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR1D—meninx—malignant glioma	0.0256	0.0736	CbGeAlD
Quetiapine—HTR3A—fourth ventricle—malignant glioma	0.025	0.0717	CbGeAlD
Quetiapine—HTR1B—dura mater—malignant glioma	0.0244	0.07	CbGeAlD
Quetiapine—Brain neoplasm—Carmustine—malignant glioma	0.0241	0.0646	CcSEcCtD
Quetiapine—HTR1D—dura mater—malignant glioma	0.0236	0.0678	CbGeAlD
Quetiapine—HTR2C—choroid plexus—malignant glioma	0.0199	0.0571	CbGeAlD
Quetiapine—DRD3—telencephalic ventricle—malignant glioma	0.0105	0.0301	CbGeAlD
Quetiapine—HTR2A—choroid plexus—malignant glioma	0.00997	0.0286	CbGeAlD
Quetiapine—DRD1—telencephalic ventricle—malignant glioma	0.0075	0.0215	CbGeAlD
Quetiapine—Hemiplegia—Carmustine—malignant glioma	0.00635	0.017	CcSEcCtD
Quetiapine—Hemiplegia—Temozolomide—malignant glioma	0.00614	0.0165	CcSEcCtD
Quetiapine—HTR1B—telencephalic ventricle—malignant glioma	0.00607	0.0174	CbGeAlD
Quetiapine—HTR1D—telencephalic ventricle—malignant glioma	0.00588	0.0169	CbGeAlD
Quetiapine—HTR2C—telencephalic ventricle—malignant glioma	0.00582	0.0167	CbGeAlD
Quetiapine—HTR7—pons—malignant glioma	0.00569	0.0163	CbGeAlD
Quetiapine—Paranoid reaction—Carmustine—malignant glioma	0.00533	0.0143	CcSEcCtD
Quetiapine—HTR2A—cerebellar cortex—malignant glioma	0.00502	0.0144	CbGeAlD
Quetiapine—HTR1A—telencephalic ventricle—malignant glioma	0.0049	0.0141	CbGeAlD
Quetiapine—HTR7—telencephalic ventricle—malignant glioma	0.00468	0.0134	CbGeAlD
Quetiapine—Disorder sight—Temozolomide—malignant glioma	0.0046	0.0124	CcSEcCtD
Quetiapine—Cerebral ischaemia—Temozolomide—malignant glioma	0.00453	0.0122	CcSEcCtD
Quetiapine—Faecal incontinence—Carmustine—malignant glioma	0.00449	0.0121	CcSEcCtD
Quetiapine—DRD2—telencephalic ventricle—malignant glioma	0.00443	0.0127	CbGeAlD
Quetiapine—Faecal incontinence—Temozolomide—malignant glioma	0.00434	0.0117	CcSEcCtD
Quetiapine—Trifluoperazine—CALY—malignant glioma	0.00378	0.354	CrCbGaD
Quetiapine—Haemorrhoids—Temozolomide—malignant glioma	0.00373	0.01	CcSEcCtD
Quetiapine—Myasthenia—Carmustine—malignant glioma	0.00361	0.00969	CcSEcCtD
Quetiapine—Deep vein thrombosis—Temozolomide—malignant glioma	0.0036	0.00967	CcSEcCtD
Quetiapine—HTR2A—pons—malignant glioma	0.00355	0.0102	CbGeAlD
Quetiapine—HTR2A—vertebral column—malignant glioma	0.00352	0.0101	CbGeAlD
Quetiapine—Aphasia—Carmustine—malignant glioma	0.0035	0.00939	CcSEcCtD
Quetiapine—HTR1E—brainstem—malignant glioma	0.00347	0.00997	CbGeAlD
Quetiapine—Aphasia—Temozolomide—malignant glioma	0.00338	0.00907	CcSEcCtD
Quetiapine—Hypokinesia—Carmustine—malignant glioma	0.00336	0.00902	CcSEcCtD
Quetiapine—Paranoia—Carmustine—malignant glioma	0.00333	0.00893	CcSEcCtD
Quetiapine—Clozapine—CALY—malignant glioma	0.00316	0.295	CrCbGaD
Quetiapine—HTR1E—telencephalon—malignant glioma	0.00308	0.00885	CbGeAlD
Quetiapine—Apathy—Temozolomide—malignant glioma	0.00307	0.00824	CcSEcCtD
Quetiapine—Flat affect—Temozolomide—malignant glioma	0.00304	0.00816	CcSEcCtD
Quetiapine—Stupor—Carmustine—malignant glioma	0.00304	0.00815	CcSEcCtD
Quetiapine—HTR1B—blood vessel—malignant glioma	0.00301	0.00863	CbGeAlD
Quetiapine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00296	0.00795	CcSEcCtD
Quetiapine—Menorrhagia—Temozolomide—malignant glioma	0.00296	0.00795	CcSEcCtD
Quetiapine—HTR2A—telencephalic ventricle—malignant glioma	0.00292	0.00839	CbGeAlD
Quetiapine—HTR1D—blood vessel—malignant glioma	0.00291	0.00836	CbGeAlD
Quetiapine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00291	0.00781	CcSEcCtD
Quetiapine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00266	0.00715	CcSEcCtD
Quetiapine—Endocrine disorder—Temozolomide—malignant glioma	0.00264	0.0071	CcSEcCtD
Quetiapine—Speech disorder—Carmustine—malignant glioma	0.00264	0.00708	CcSEcCtD
Quetiapine—Accidental injury—Carmustine—malignant glioma	0.00256	0.00688	CcSEcCtD
Quetiapine—Speech disorder—Temozolomide—malignant glioma	0.00255	0.00684	CcSEcCtD
Quetiapine—HTR2A—pineal body—malignant glioma	0.00253	0.00727	CbGeAlD
Quetiapine—Disturbance in attention—Temozolomide—malignant glioma	0.00253	0.00679	CcSEcCtD
Quetiapine—HTR7—endothelium—malignant glioma	0.00251	0.00722	CbGeAlD
Quetiapine—Amenorrhoea—Temozolomide—malignant glioma	0.00249	0.0067	CcSEcCtD
Quetiapine—Thinking abnormal—Carmustine—malignant glioma	0.00248	0.00665	CcSEcCtD
Quetiapine—Drug interaction—Carmustine—malignant glioma	0.00244	0.00656	CcSEcCtD
Quetiapine—HTR6—telencephalon—malignant glioma	0.00242	0.00695	CbGeAlD
Quetiapine—Leukocytosis—Carmustine—malignant glioma	0.00241	0.00648	CcSEcCtD
Quetiapine—DRD5—telencephalon—malignant glioma	0.00236	0.00676	CbGeAlD
Quetiapine—Gait disturbance—Carmustine—malignant glioma	0.00232	0.00624	CcSEcCtD
Quetiapine—HTR7—blood vessel—malignant glioma	0.00232	0.00666	CbGeAlD
Quetiapine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00232	0.00622	CcSEcCtD
Quetiapine—Coordination abnormal—Carmustine—malignant glioma	0.00231	0.0062	CcSEcCtD
Quetiapine—Neck pain—Carmustine—malignant glioma	0.0023	0.00616	CcSEcCtD
Quetiapine—Pulmonary embolism—Carmustine—malignant glioma	0.00227	0.00609	CcSEcCtD
Quetiapine—Gait disturbance—Temozolomide—malignant glioma	0.00225	0.00603	CcSEcCtD
Quetiapine—H1F0—embryo—malignant glioma	0.00224	0.00643	CbGeAlD
Quetiapine—Coordination abnormal—Temozolomide—malignant glioma	0.00223	0.00599	CcSEcCtD
Quetiapine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00219	0.00588	CcSEcCtD
Quetiapine—Vaginal inflammation—Temozolomide—malignant glioma	0.00219	0.00588	CcSEcCtD
Quetiapine—Pulmonary embolism—Temozolomide—malignant glioma	0.00219	0.00588	CcSEcCtD
Quetiapine—Depressed level of consciousness—Carmustine—malignant glioma	0.00219	0.00588	CcSEcCtD
Quetiapine—Urinary incontinence—Carmustine—malignant glioma	0.00219	0.00588	CcSEcCtD
Quetiapine—Candida infection—Carmustine—malignant glioma	0.00216	0.00581	CcSEcCtD
Quetiapine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00212	0.00568	CcSEcCtD
Quetiapine—Urinary incontinence—Temozolomide—malignant glioma	0.00212	0.00568	CcSEcCtD
Quetiapine—Candida infection—Temozolomide—malignant glioma	0.00209	0.00562	CcSEcCtD
Quetiapine—Vaginal infection—Temozolomide—malignant glioma	0.00207	0.00555	CcSEcCtD
Quetiapine—Neoplasm—Carmustine—malignant glioma	0.00205	0.0055	CcSEcCtD
Quetiapine—Gynaecomastia—Carmustine—malignant glioma	0.00203	0.00545	CcSEcCtD
Quetiapine—DRD1—brainstem—malignant glioma	0.00203	0.00582	CbGeAlD
Quetiapine—Dry eye—Temozolomide—malignant glioma	0.00202	0.00543	CcSEcCtD
Quetiapine—H1F0—retina—malignant glioma	0.00198	0.00569	CbGeAlD
Quetiapine—Neoplasm—Temozolomide—malignant glioma	0.00198	0.00532	CcSEcCtD
Quetiapine—Abnormal vision—Carmustine—malignant glioma	0.00198	0.00531	CcSEcCtD
Quetiapine—Mental disability—Carmustine—malignant glioma	0.00197	0.00528	CcSEcCtD
Quetiapine—HTR3A—brainstem—malignant glioma	0.00196	0.00562	CbGeAlD
Quetiapine—Abnormal vision—Temozolomide—malignant glioma	0.00191	0.00513	CcSEcCtD
Quetiapine—Mental disability—Temozolomide—malignant glioma	0.0019	0.00511	CcSEcCtD
Quetiapine—Thrombophlebitis—Carmustine—malignant glioma	0.0019	0.0051	CcSEcCtD
Quetiapine—Diabetes mellitus—Carmustine—malignant glioma	0.00189	0.00508	CcSEcCtD
Quetiapine—ADRA1D—telencephalon—malignant glioma	0.00189	0.00542	CbGeAlD
Quetiapine—Ear pain—Temozolomide—malignant glioma	0.00186	0.00501	CcSEcCtD
Quetiapine—Thrombophlebitis—Temozolomide—malignant glioma	0.00184	0.00493	CcSEcCtD
Quetiapine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00183	0.00491	CcSEcCtD
Quetiapine—Eye pain—Carmustine—malignant glioma	0.00182	0.00489	CcSEcCtD
Quetiapine—H1F0—telencephalon—malignant glioma	0.00182	0.00523	CbGeAlD
Quetiapine—DRD1—telencephalon—malignant glioma	0.0018	0.00517	CbGeAlD
Quetiapine—Gastroenteritis—Temozolomide—malignant glioma	0.00179	0.00482	CcSEcCtD
Quetiapine—Injury—Carmustine—malignant glioma	0.00179	0.00481	CcSEcCtD
Quetiapine—Deafness—Temozolomide—malignant glioma	0.00178	0.00477	CcSEcCtD
Quetiapine—Eye pain—Temozolomide—malignant glioma	0.00176	0.00473	CcSEcCtD
Quetiapine—HTR1E—central nervous system—malignant glioma	0.00175	0.00503	CbGeAlD
Quetiapine—Amnesia—Carmustine—malignant glioma	0.00175	0.0047	CcSEcCtD
Quetiapine—Nasal congestion—Temozolomide—malignant glioma	0.00175	0.00469	CcSEcCtD
Quetiapine—HTR3A—telencephalon—malignant glioma	0.00174	0.00499	CbGeAlD
Quetiapine—Hot flush—Temozolomide—malignant glioma	0.0017	0.00457	CcSEcCtD
Quetiapine—Amnesia—Temozolomide—malignant glioma	0.00169	0.00455	CcSEcCtD
Quetiapine—Menopausal symptoms—Temozolomide—malignant glioma	0.00169	0.00453	CcSEcCtD
Quetiapine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00169	0.00453	CcSEcCtD
Quetiapine—Thirst—Temozolomide—malignant glioma	0.00167	0.00449	CcSEcCtD
Quetiapine—Hyponatraemia—Carmustine—malignant glioma	0.00165	0.00444	CcSEcCtD
Quetiapine—HTR1B—brainstem—malignant glioma	0.00164	0.00472	CbGeAlD
Quetiapine—DRD4—brain—malignant glioma	0.00161	0.00463	CbGeAlD
Quetiapine—HTR1D—brainstem—malignant glioma	0.00159	0.00457	CbGeAlD
Quetiapine—Face oedema—Carmustine—malignant glioma	0.00159	0.00427	CcSEcCtD
Quetiapine—HTR2C—brainstem—malignant glioma	0.00158	0.00452	CbGeAlD
Quetiapine—HTR2A—endothelium—malignant glioma	0.00157	0.0045	CbGeAlD
Quetiapine—Affect lability—Temozolomide—malignant glioma	0.00157	0.0042	CcSEcCtD
Quetiapine—Ataxia—Carmustine—malignant glioma	0.00155	0.00416	CcSEcCtD
Quetiapine—CHRM4—central nervous system—malignant glioma	0.00154	0.00441	CbGeAlD
Quetiapine—Face oedema—Temozolomide—malignant glioma	0.00154	0.00412	CcSEcCtD
Quetiapine—Mood swings—Temozolomide—malignant glioma	0.00151	0.00405	CcSEcCtD
Quetiapine—Hypokalaemia—Carmustine—malignant glioma	0.0015	0.00402	CcSEcCtD
Quetiapine—Ataxia—Temozolomide—malignant glioma	0.0015	0.00402	CcSEcCtD
Quetiapine—Dehydration—Temozolomide—malignant glioma	0.00148	0.00397	CcSEcCtD
Quetiapine—HTR1B—telencephalon—malignant glioma	0.00146	0.00419	CbGeAlD
Quetiapine—Dry skin—Temozolomide—malignant glioma	0.00146	0.00391	CcSEcCtD
Quetiapine—Muscular weakness—Carmustine—malignant glioma	0.00145	0.0039	CcSEcCtD
Quetiapine—CHRM2—telencephalon—malignant glioma	0.00145	0.00416	CbGeAlD
Quetiapine—Hypokalaemia—Temozolomide—malignant glioma	0.00145	0.00389	CcSEcCtD
Quetiapine—HTR2A—blood vessel—malignant glioma	0.00145	0.00415	CbGeAlD
Quetiapine—Breast disorder—Temozolomide—malignant glioma	0.00144	0.00386	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00143	0.00385	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00143	0.00385	CcSEcCtD
Quetiapine—H1F0—medulla oblongata—malignant glioma	0.00143	0.00411	CbGeAlD
Quetiapine—DRD3—central nervous system—malignant glioma	0.00143	0.0041	CbGeAlD
Quetiapine—Dysphagia—Carmustine—malignant glioma	0.00142	0.00382	CcSEcCtD
Quetiapine—HTR1D—telencephalon—malignant glioma	0.00141	0.00405	CbGeAlD
Quetiapine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0014	0.00377	CcSEcCtD
Quetiapine—Muscular weakness—Temozolomide—malignant glioma	0.0014	0.00377	CcSEcCtD
Quetiapine—HTR2C—telencephalon—malignant glioma	0.0014	0.00401	CbGeAlD
Quetiapine—HTR1E—brain—malignant glioma	0.00139	0.00399	CbGeAlD
Quetiapine—Abdominal distension—Temozolomide—malignant glioma	0.00138	0.00372	CcSEcCtD
Quetiapine—HTR6—central nervous system—malignant glioma	0.00138	0.00395	CbGeAlD
Quetiapine—Dysphagia—Temozolomide—malignant glioma	0.00137	0.00369	CcSEcCtD
Quetiapine—DRD5—central nervous system—malignant glioma	0.00134	0.00384	CbGeAlD
Quetiapine—Neutropenia—Carmustine—malignant glioma	0.00133	0.00357	CcSEcCtD
Quetiapine—HTR1A—brainstem—malignant glioma	0.00133	0.00381	CbGeAlD
Quetiapine—Bronchitis—Temozolomide—malignant glioma	0.00132	0.00355	CcSEcCtD
Quetiapine—CHRM1—telencephalon—malignant glioma	0.00132	0.00379	CbGeAlD
Quetiapine—H1F0—midbrain—malignant glioma	0.00131	0.00376	CbGeAlD
Quetiapine—DRD1—midbrain—malignant glioma	0.00129	0.00371	CbGeAlD
Quetiapine—Neutropenia—Temozolomide—malignant glioma	0.00129	0.00345	CcSEcCtD
Quetiapine—Dysuria—Temozolomide—malignant glioma	0.00129	0.00345	CcSEcCtD
Quetiapine—Hyperglycaemia—Carmustine—malignant glioma	0.00128	0.00345	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00128	0.00343	CcSEcCtD
Quetiapine—H1F0—spinal cord—malignant glioma	0.00128	0.00367	CbGeAlD
Quetiapine—Pneumonia—Carmustine—malignant glioma	0.00128	0.00343	CcSEcCtD
Quetiapine—Pollakiuria—Temozolomide—malignant glioma	0.00127	0.00341	CcSEcCtD
Quetiapine—HTR7—brainstem—malignant glioma	0.00127	0.00364	CbGeAlD
Quetiapine—Erectile dysfunction—Temozolomide—malignant glioma	0.00127	0.0034	CcSEcCtD
Quetiapine—Depression—Carmustine—malignant glioma	0.00126	0.0034	CcSEcCtD
Quetiapine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00125	0.00337	CcSEcCtD
Quetiapine—Weight increased—Temozolomide—malignant glioma	0.00125	0.00336	CcSEcCtD
Quetiapine—Weight decreased—Temozolomide—malignant glioma	0.00124	0.00334	CcSEcCtD
Quetiapine—Hyperglycaemia—Temozolomide—malignant glioma	0.00124	0.00333	CcSEcCtD
Quetiapine—Stomatitis—Carmustine—malignant glioma	0.00124	0.00332	CcSEcCtD
Quetiapine—Urinary tract infection—Carmustine—malignant glioma	0.00123	0.00331	CcSEcCtD
Quetiapine—Pneumonia—Temozolomide—malignant glioma	0.00123	0.00331	CcSEcCtD
Quetiapine—Infestation—Temozolomide—malignant glioma	0.00123	0.00329	CcSEcCtD
Quetiapine—Infestation NOS—Temozolomide—malignant glioma	0.00123	0.00329	CcSEcCtD
Quetiapine—ADRA1A—brainstem—malignant glioma	0.00122	0.00351	CbGeAlD
Quetiapine—Depression—Temozolomide—malignant glioma	0.00122	0.00328	CcSEcCtD
Quetiapine—CHRM4—brain—malignant glioma	0.00122	0.0035	CbGeAlD
Quetiapine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00122	0.00326	CcSEcCtD
Quetiapine—CHRM5—central nervous system—malignant glioma	0.0012	0.00345	CbGeAlD
Quetiapine—DRD2—brainstem—malignant glioma	0.0012	0.00344	CbGeAlD
Quetiapine—Stomatitis—Temozolomide—malignant glioma	0.00119	0.00321	CcSEcCtD
Quetiapine—Urinary tract infection—Temozolomide—malignant glioma	0.00119	0.0032	CcSEcCtD
Quetiapine—CHRM3—telencephalon—malignant glioma	0.00118	0.00339	CbGeAlD
Quetiapine—HTR1A—telencephalon—malignant glioma	0.00118	0.00338	CbGeAlD
Quetiapine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00116	0.00311	CcSEcCtD
Quetiapine—DRD2—retina—malignant glioma	0.00116	0.00332	CbGeAlD
Quetiapine—Sinusitis—Temozolomide—malignant glioma	0.00115	0.00309	CcSEcCtD
Quetiapine—Haemoglobin—Carmustine—malignant glioma	0.00114	0.00307	CcSEcCtD
Quetiapine—Haemorrhage—Carmustine—malignant glioma	0.00114	0.00306	CcSEcCtD
Quetiapine—DRD3—brain—malignant glioma	0.00113	0.00326	CbGeAlD
Quetiapine—Hypoaesthesia—Carmustine—malignant glioma	0.00113	0.00304	CcSEcCtD
Quetiapine—Hallucination—Carmustine—malignant glioma	0.00113	0.00304	CcSEcCtD
Quetiapine—HTR7—telencephalon—malignant glioma	0.00112	0.00323	CbGeAlD
Quetiapine—Oedema peripheral—Carmustine—malignant glioma	0.00112	0.00301	CcSEcCtD
Quetiapine—Connective tissue disorder—Carmustine—malignant glioma	0.00112	0.003	CcSEcCtD
Quetiapine—Haemoglobin—Temozolomide—malignant glioma	0.00111	0.00297	CcSEcCtD
Quetiapine—Haemorrhage—Temozolomide—malignant glioma	0.0011	0.00295	CcSEcCtD
Quetiapine—Hepatitis—Temozolomide—malignant glioma	0.0011	0.00295	CcSEcCtD
Quetiapine—HTR2C—medulla oblongata—malignant glioma	0.0011	0.00315	CbGeAlD
Quetiapine—ADRA1B—central nervous system—malignant glioma	0.0011	0.00315	CbGeAlD
Quetiapine—Visual impairment—Carmustine—malignant glioma	0.0011	0.00295	CcSEcCtD
Quetiapine—Hypoaesthesia—Temozolomide—malignant glioma	0.00109	0.00294	CcSEcCtD
Quetiapine—Hallucination—Temozolomide—malignant glioma	0.00109	0.00294	CcSEcCtD
Quetiapine—Pharyngitis—Temozolomide—malignant glioma	0.00109	0.00293	CcSEcCtD
Quetiapine—HTR6—brain—malignant glioma	0.00109	0.00313	CbGeAlD
Quetiapine—Urinary tract disorder—Temozolomide—malignant glioma	0.00109	0.00292	CcSEcCtD
Quetiapine—ADRA1A—telencephalon—malignant glioma	0.00108	0.00311	CbGeAlD
Quetiapine—Oedema peripheral—Temozolomide—malignant glioma	0.00108	0.00291	CcSEcCtD
Quetiapine—Connective tissue disorder—Temozolomide—malignant glioma	0.00108	0.0029	CcSEcCtD
Quetiapine—Urethral disorder—Temozolomide—malignant glioma	0.00108	0.0029	CcSEcCtD
Quetiapine—ADRA1D—central nervous system—malignant glioma	0.00107	0.00308	CbGeAlD
Quetiapine—Eye disorder—Carmustine—malignant glioma	0.00106	0.00286	CcSEcCtD
Quetiapine—DRD2—telencephalon—malignant glioma	0.00106	0.00305	CbGeAlD
Quetiapine—DRD5—brain—malignant glioma	0.00106	0.00305	CbGeAlD
Quetiapine—Visual impairment—Temozolomide—malignant glioma	0.00106	0.00285	CcSEcCtD
Quetiapine—HTR1B—midbrain—malignant glioma	0.00105	0.00301	CbGeAlD
Quetiapine—Erythema multiforme—Temozolomide—malignant glioma	0.00104	0.00279	CcSEcCtD
Quetiapine—H1F0—central nervous system—malignant glioma	0.00104	0.00297	CbGeAlD
Quetiapine—ADRA2C—telencephalon—malignant glioma	0.00103	0.00297	CbGeAlD
Quetiapine—Eye disorder—Temozolomide—malignant glioma	0.00103	0.00276	CcSEcCtD
Quetiapine—Tinnitus—Temozolomide—malignant glioma	0.00103	0.00275	CcSEcCtD
Quetiapine—DRD1—central nervous system—malignant glioma	0.00102	0.00294	CbGeAlD
Quetiapine—HTR1B—spinal cord—malignant glioma	0.00102	0.00293	CbGeAlD
Quetiapine—Cardiac disorder—Temozolomide—malignant glioma	0.00102	0.00274	CcSEcCtD
Quetiapine—HTR1D—midbrain—malignant glioma	0.00101	0.00291	CbGeAlD
Quetiapine—H1F0—cerebellum—malignant glioma	0.00101	0.00291	CbGeAlD
Quetiapine—HTR2C—midbrain—malignant glioma	0.001	0.00288	CbGeAlD
Quetiapine—Angiopathy—Temozolomide—malignant glioma	0.000998	0.00268	CcSEcCtD
Quetiapine—Mental disorder—Carmustine—malignant glioma	0.000998	0.00268	CcSEcCtD
Quetiapine—Immune system disorder—Temozolomide—malignant glioma	0.000994	0.00267	CcSEcCtD
Quetiapine—Mediastinal disorder—Temozolomide—malignant glioma	0.000992	0.00266	CcSEcCtD
Quetiapine—Malnutrition—Carmustine—malignant glioma	0.000991	0.00266	CcSEcCtD
Quetiapine—HTR3A—central nervous system—malignant glioma	0.000988	0.00284	CbGeAlD
Quetiapine—Chills—Temozolomide—malignant glioma	0.000987	0.00265	CcSEcCtD
Quetiapine—HTR2C—spinal cord—malignant glioma	0.00098	0.00281	CbGeAlD
Quetiapine—Mental disorder—Temozolomide—malignant glioma	0.000964	0.00259	CcSEcCtD
Quetiapine—Back pain—Carmustine—malignant glioma	0.000959	0.00257	CcSEcCtD
Quetiapine—Malnutrition—Temozolomide—malignant glioma	0.000958	0.00257	CcSEcCtD
Quetiapine—CHRM5—brain—malignant glioma	0.000954	0.00274	CbGeAlD
Quetiapine—ABCB1—blood vessel—malignant glioma	0.000947	0.00272	CbGeAlD
Quetiapine—Nefazodone—SLC6A3—malignant glioma	0.000939	0.0879	CrCbGaD
Quetiapine—Dysgeusia—Temozolomide—malignant glioma	0.000938	0.00252	CcSEcCtD
Quetiapine—Vision blurred—Carmustine—malignant glioma	0.000934	0.00251	CcSEcCtD
Quetiapine—Tremor—Carmustine—malignant glioma	0.000929	0.00249	CcSEcCtD
Quetiapine—Back pain—Temozolomide—malignant glioma	0.000927	0.00249	CcSEcCtD
Quetiapine—Anaemia—Carmustine—malignant glioma	0.000916	0.00246	CcSEcCtD
Quetiapine—Agitation—Carmustine—malignant glioma	0.000911	0.00245	CcSEcCtD
Quetiapine—Vision blurred—Temozolomide—malignant glioma	0.000903	0.00242	CcSEcCtD
Quetiapine—Tremor—Temozolomide—malignant glioma	0.000898	0.00241	CcSEcCtD
Quetiapine—Ill-defined disorder—Temozolomide—malignant glioma	0.000889	0.00239	CcSEcCtD
Quetiapine—Leukopenia—Carmustine—malignant glioma	0.000887	0.00238	CcSEcCtD
Quetiapine—Anaemia—Temozolomide—malignant glioma	0.000885	0.00238	CcSEcCtD
Quetiapine—HTR7—medulla oblongata—malignant glioma	0.000884	0.00254	CbGeAlD
Quetiapine—Agitation—Temozolomide—malignant glioma	0.00088	0.00236	CcSEcCtD
Quetiapine—Perphenazine—CYP2C18—malignant glioma	0.000879	0.0823	CrCbGaD
Quetiapine—Angioedema—Temozolomide—malignant glioma	0.000875	0.00235	CcSEcCtD
Quetiapine—ADRA1B—brain—malignant glioma	0.000871	0.0025	CbGeAlD
Quetiapine—Malaise—Temozolomide—malignant glioma	0.000864	0.00232	CcSEcCtD
Quetiapine—HTR2A—embryo—malignant glioma	0.000862	0.00248	CbGeAlD
Quetiapine—Vertigo—Temozolomide—malignant glioma	0.000861	0.00231	CcSEcCtD
Quetiapine—Convulsion—Carmustine—malignant glioma	0.000859	0.00231	CcSEcCtD
Quetiapine—Leukopenia—Temozolomide—malignant glioma	0.000857	0.0023	CcSEcCtD
Quetiapine—Hypertension—Carmustine—malignant glioma	0.000856	0.0023	CcSEcCtD
Quetiapine—ADRA1D—brain—malignant glioma	0.000852	0.00245	CbGeAlD
Quetiapine—Palpitations—Temozolomide—malignant glioma	0.000847	0.00227	CcSEcCtD
Quetiapine—HTR1A—midbrain—malignant glioma	0.000845	0.00243	CbGeAlD
Quetiapine—Myalgia—Carmustine—malignant glioma	0.000844	0.00227	CcSEcCtD
Quetiapine—Chest pain—Carmustine—malignant glioma	0.000844	0.00227	CcSEcCtD
Quetiapine—Anxiety—Carmustine—malignant glioma	0.000841	0.00226	CcSEcCtD
Quetiapine—HRH1—telencephalon—malignant glioma	0.00084	0.00241	CbGeAlD
Quetiapine—Cough—Temozolomide—malignant glioma	0.000836	0.00224	CcSEcCtD
Quetiapine—Convulsion—Temozolomide—malignant glioma	0.00083	0.00223	CcSEcCtD
Quetiapine—HTR1B—central nervous system—malignant glioma	0.000829	0.00238	CbGeAlD
Quetiapine—Hypertension—Temozolomide—malignant glioma	0.000827	0.00222	CcSEcCtD
Quetiapine—ADRA2A—telencephalon—malignant glioma	0.000825	0.00237	CbGeAlD
Quetiapine—HTR1A—spinal cord—malignant glioma	0.000825	0.00237	CbGeAlD
Quetiapine—CHRM2—central nervous system—malignant glioma	0.000825	0.00237	CbGeAlD
Quetiapine—H1F0—brain—malignant glioma	0.000822	0.00236	CbGeAlD
Quetiapine—Confusional state—Carmustine—malignant glioma	0.000816	0.00219	CcSEcCtD
Quetiapine—Myalgia—Temozolomide—malignant glioma	0.000816	0.00219	CcSEcCtD
Quetiapine—Arthralgia—Temozolomide—malignant glioma	0.000816	0.00219	CcSEcCtD
Quetiapine—Anxiety—Temozolomide—malignant glioma	0.000813	0.00218	CcSEcCtD
Quetiapine—ADRA2C—medulla oblongata—malignant glioma	0.000812	0.00233	CbGeAlD
Quetiapine—DRD1—brain—malignant glioma	0.000812	0.00233	CbGeAlD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00081	0.00217	CcSEcCtD
Quetiapine—HTR7—midbrain—malignant glioma	0.000808	0.00232	CbGeAlD
Quetiapine—Discomfort—Temozolomide—malignant glioma	0.000806	0.00216	CcSEcCtD
Quetiapine—Infection—Carmustine—malignant glioma	0.000804	0.00216	CcSEcCtD
Quetiapine—HTR1D—central nervous system—malignant glioma	0.000803	0.0023	CbGeAlD
Quetiapine—Dry mouth—Temozolomide—malignant glioma	0.000798	0.00214	CcSEcCtD
Quetiapine—HTR2C—central nervous system—malignant glioma	0.000795	0.00228	CbGeAlD
Quetiapine—Thrombocytopenia—Carmustine—malignant glioma	0.000792	0.00213	CcSEcCtD
Quetiapine—HTR2A—brainstem—malignant glioma	0.00079	0.00227	CbGeAlD
Quetiapine—Tachycardia—Carmustine—malignant glioma	0.00079	0.00212	CcSEcCtD
Quetiapine—Confusional state—Temozolomide—malignant glioma	0.000788	0.00212	CcSEcCtD
Quetiapine—HTR7—spinal cord—malignant glioma	0.000788	0.00226	CbGeAlD
Quetiapine—HTR3A—brain—malignant glioma	0.000784	0.00225	CbGeAlD
Quetiapine—Anaphylactic shock—Temozolomide—malignant glioma	0.000782	0.0021	CcSEcCtD
Quetiapine—Infection—Temozolomide—malignant glioma	0.000777	0.00209	CcSEcCtD
Quetiapine—Anorexia—Carmustine—malignant glioma	0.000771	0.00207	CcSEcCtD
Quetiapine—Nervous system disorder—Temozolomide—malignant glioma	0.000767	0.00206	CcSEcCtD
Quetiapine—Thrombocytopenia—Temozolomide—malignant glioma	0.000765	0.00206	CcSEcCtD
Quetiapine—DRD2—midbrain—malignant glioma	0.000764	0.00219	CbGeAlD
Quetiapine—HTR2A—retina—malignant glioma	0.000762	0.00219	CbGeAlD
Quetiapine—Skin disorder—Temozolomide—malignant glioma	0.000759	0.00204	CcSEcCtD
Quetiapine—Hypotension—Carmustine—malignant glioma	0.000756	0.00203	CcSEcCtD
Quetiapine—Hyperhidrosis—Temozolomide—malignant glioma	0.000756	0.00203	CcSEcCtD
Quetiapine—CHRM1—central nervous system—malignant glioma	0.00075	0.00215	CbGeAlD
Quetiapine—Anorexia—Temozolomide—malignant glioma	0.000745	0.002	CcSEcCtD
Quetiapine—ADRA2C—midbrain—malignant glioma	0.000742	0.00213	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000737	0.00198	CcSEcCtD
Quetiapine—Insomnia—Carmustine—malignant glioma	0.000732	0.00196	CcSEcCtD
Quetiapine—Paraesthesia—Carmustine—malignant glioma	0.000726	0.00195	CcSEcCtD
Quetiapine—ADRA2C—spinal cord—malignant glioma	0.000724	0.00208	CbGeAlD
Quetiapine—Dyspnoea—Carmustine—malignant glioma	0.000721	0.00194	CcSEcCtD
Quetiapine—CYP2D6—brainstem—malignant glioma	0.00072	0.00207	CbGeAlD
Quetiapine—Somnolence—Carmustine—malignant glioma	0.000719	0.00193	CcSEcCtD
Quetiapine—Amoxapine—SLC6A3—malignant glioma	0.000716	0.067	CrCbGaD
Quetiapine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000712	0.00191	CcSEcCtD
Quetiapine—Insomnia—Temozolomide—malignant glioma	0.000707	0.0019	CcSEcCtD
Quetiapine—Decreased appetite—Carmustine—malignant glioma	0.000703	0.00189	CcSEcCtD
Quetiapine—Paraesthesia—Temozolomide—malignant glioma	0.000702	0.00188	CcSEcCtD
Quetiapine—HTR2A—telencephalon—malignant glioma	0.000701	0.00201	CbGeAlD
Quetiapine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000698	0.00188	CcSEcCtD
Quetiapine—Dyspnoea—Temozolomide—malignant glioma	0.000697	0.00187	CcSEcCtD
Quetiapine—Somnolence—Temozolomide—malignant glioma	0.000695	0.00187	CcSEcCtD
Quetiapine—Pain—Carmustine—malignant glioma	0.000692	0.00186	CcSEcCtD
Quetiapine—Constipation—Carmustine—malignant glioma	0.000692	0.00186	CcSEcCtD
Quetiapine—Dyspepsia—Temozolomide—malignant glioma	0.000688	0.00185	CcSEcCtD
Quetiapine—Decreased appetite—Temozolomide—malignant glioma	0.00068	0.00182	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000675	0.00181	CcSEcCtD
Quetiapine—Fatigue—Temozolomide—malignant glioma	0.000674	0.00181	CcSEcCtD
Quetiapine—CHRM3—central nervous system—malignant glioma	0.000672	0.00193	CbGeAlD
Quetiapine—HTR1A—central nervous system—malignant glioma	0.000669	0.00192	CbGeAlD
Quetiapine—Pain—Temozolomide—malignant glioma	0.000669	0.00179	CcSEcCtD
Quetiapine—Constipation—Temozolomide—malignant glioma	0.000669	0.00179	CcSEcCtD
Quetiapine—Feeling abnormal—Carmustine—malignant glioma	0.000667	0.00179	CcSEcCtD
Quetiapine—Gastrointestinal pain—Carmustine—malignant glioma	0.000662	0.00178	CcSEcCtD
Quetiapine—HTR1B—brain—malignant glioma	0.000658	0.00189	CbGeAlD
Quetiapine—CHRM2—brain—malignant glioma	0.000655	0.00188	CbGeAlD
Quetiapine—HTR1A—cerebellum—malignant glioma	0.000654	0.00188	CbGeAlD
Quetiapine—Perphenazine—CYP2B6—malignant glioma	0.000653	0.0611	CrCbGaD
Quetiapine—ADRA2A—medulla oblongata—malignant glioma	0.000648	0.00186	CbGeAlD
Quetiapine—Feeling abnormal—Temozolomide—malignant glioma	0.000644	0.00173	CcSEcCtD
Quetiapine—Body temperature increased—Carmustine—malignant glioma	0.00064	0.00172	CcSEcCtD
Quetiapine—Abdominal pain—Carmustine—malignant glioma	0.00064	0.00172	CcSEcCtD
Quetiapine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000639	0.00172	CcSEcCtD
Quetiapine—HTR7—central nervous system—malignant glioma	0.000639	0.00184	CbGeAlD
Quetiapine—CYP2D6—telencephalon—malignant glioma	0.000639	0.00183	CbGeAlD
Quetiapine—HTR1D—brain—malignant glioma	0.000637	0.00183	CbGeAlD
Quetiapine—HTR2C—brain—malignant glioma	0.000631	0.00181	CbGeAlD
Quetiapine—HTR7—cerebellum—malignant glioma	0.000625	0.00179	CbGeAlD
Quetiapine—Body temperature increased—Temozolomide—malignant glioma	0.000618	0.00166	CcSEcCtD
Quetiapine—Abdominal pain—Temozolomide—malignant glioma	0.000618	0.00166	CcSEcCtD
Quetiapine—ADRA1A—central nervous system—malignant glioma	0.000617	0.00177	CbGeAlD
Quetiapine—DRD2—central nervous system—malignant glioma	0.000604	0.00174	CbGeAlD
Quetiapine—ADRA1A—cerebellum—malignant glioma	0.000603	0.00173	CbGeAlD
Quetiapine—Hypersensitivity—Carmustine—malignant glioma	0.000596	0.0016	CcSEcCtD
Quetiapine—CHRM1—brain—malignant glioma	0.000596	0.00171	CbGeAlD
Quetiapine—ADRA2A—midbrain—malignant glioma	0.000592	0.0017	CbGeAlD
Quetiapine—DRD2—cerebellum—malignant glioma	0.000591	0.0017	CbGeAlD
Quetiapine—ADRA2C—central nervous system—malignant glioma	0.000588	0.00169	CbGeAlD
Quetiapine—Asthenia—Carmustine—malignant glioma	0.00058	0.00156	CcSEcCtD
Quetiapine—ADRA2A—spinal cord—malignant glioma	0.000578	0.00166	CbGeAlD
Quetiapine—Hypersensitivity—Temozolomide—malignant glioma	0.000576	0.00155	CcSEcCtD
Quetiapine—ADRA2C—cerebellum—malignant glioma	0.000574	0.00165	CbGeAlD
Quetiapine—ABCB1—embryo—malignant glioma	0.000565	0.00162	CbGeAlD
Quetiapine—Asthenia—Temozolomide—malignant glioma	0.000561	0.00151	CcSEcCtD
Quetiapine—Loxapine—SLC6A3—malignant glioma	0.000559	0.0523	CrCbGaD
Quetiapine—Diarrhoea—Carmustine—malignant glioma	0.000554	0.00149	CcSEcCtD
Quetiapine—Pruritus—Temozolomide—malignant glioma	0.000553	0.00148	CcSEcCtD
Quetiapine—HTR2A—medulla oblongata—malignant glioma	0.000551	0.00158	CbGeAlD
Quetiapine—Dizziness—Carmustine—malignant glioma	0.000535	0.00144	CcSEcCtD
Quetiapine—Diarrhoea—Temozolomide—malignant glioma	0.000535	0.00144	CcSEcCtD
Quetiapine—CHRM3—brain—malignant glioma	0.000533	0.00153	CbGeAlD
Quetiapine—HTR1A—brain—malignant glioma	0.000531	0.00152	CbGeAlD
Quetiapine—Dizziness—Temozolomide—malignant glioma	0.000517	0.00139	CcSEcCtD
Quetiapine—Vomiting—Carmustine—malignant glioma	0.000514	0.00138	CcSEcCtD
Quetiapine—Rash—Carmustine—malignant glioma	0.00051	0.00137	CcSEcCtD
Quetiapine—Dermatitis—Carmustine—malignant glioma	0.00051	0.00137	CcSEcCtD
Quetiapine—HTR7—brain—malignant glioma	0.000508	0.00146	CbGeAlD
Quetiapine—Headache—Carmustine—malignant glioma	0.000507	0.00136	CcSEcCtD
Quetiapine—HTR2A—midbrain—malignant glioma	0.000504	0.00145	CbGeAlD
Quetiapine—ABCB1—retina—malignant glioma	0.0005	0.00143	CbGeAlD
Quetiapine—Vomiting—Temozolomide—malignant glioma	0.000497	0.00133	CcSEcCtD
Quetiapine—Rash—Temozolomide—malignant glioma	0.000493	0.00132	CcSEcCtD
Quetiapine—Dermatitis—Temozolomide—malignant glioma	0.000492	0.00132	CcSEcCtD
Quetiapine—HTR2A—spinal cord—malignant glioma	0.000491	0.00141	CbGeAlD
Quetiapine—Headache—Temozolomide—malignant glioma	0.00049	0.00131	CcSEcCtD
Quetiapine—ADRA1A—brain—malignant glioma	0.00049	0.00141	CbGeAlD
Quetiapine—Nausea—Carmustine—malignant glioma	0.000481	0.00129	CcSEcCtD
Quetiapine—DRD2—brain—malignant glioma	0.00048	0.00138	CbGeAlD
Quetiapine—HRH1—central nervous system—malignant glioma	0.000477	0.00137	CbGeAlD
Quetiapine—ADRA2A—central nervous system—malignant glioma	0.000469	0.00135	CbGeAlD
Quetiapine—ADRA2C—brain—malignant glioma	0.000466	0.00134	CbGeAlD
Quetiapine—Nausea—Temozolomide—malignant glioma	0.000464	0.00125	CcSEcCtD
Quetiapine—ABCB1—telencephalon—malignant glioma	0.00046	0.00132	CbGeAlD
Quetiapine—ADRA2A—cerebellum—malignant glioma	0.000458	0.00132	CbGeAlD
Quetiapine—HTR2A—central nervous system—malignant glioma	0.000399	0.00114	CbGeAlD
Quetiapine—HTR2A—cerebellum—malignant glioma	0.00039	0.00112	CbGeAlD
Quetiapine—HRH1—brain—malignant glioma	0.000379	0.00109	CbGeAlD
Quetiapine—ADRA2A—brain—malignant glioma	0.000372	0.00107	CbGeAlD
Quetiapine—CYP3A4—central nervous system—malignant glioma	0.000369	0.00106	CbGeAlD
Quetiapine—CYP2D6—central nervous system—malignant glioma	0.000363	0.00104	CbGeAlD
Quetiapine—ABCB1—medulla oblongata—malignant glioma	0.000361	0.00104	CbGeAlD
Quetiapine—CYP2D6—cerebellum—malignant glioma	0.000355	0.00102	CbGeAlD
Quetiapine—ABCB1—midbrain—malignant glioma	0.00033	0.000948	CbGeAlD
Quetiapine—ABCB1—spinal cord—malignant glioma	0.000322	0.000924	CbGeAlD
Quetiapine—HTR2A—brain—malignant glioma	0.000316	0.000909	CbGeAlD
Quetiapine—CYP2D6—brain—malignant glioma	0.000288	0.000828	CbGeAlD
Quetiapine—ABCB1—central nervous system—malignant glioma	0.000261	0.00075	CbGeAlD
Quetiapine—ABCB1—cerebellum—malignant glioma	0.000255	0.000733	CbGeAlD
Quetiapine—ABCB1—brain—malignant glioma	0.000207	0.000595	CbGeAlD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	8.86e-06	3.3e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	8.84e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MYC—malignant glioma	8.82e-06	3.28e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MYC—malignant glioma	8.82e-06	3.28e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	8.81e-06	3.28e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	8.81e-06	3.28e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	8.81e-06	3.28e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	8.8e-06	3.28e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—malignant glioma	8.76e-06	3.26e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	8.75e-06	3.26e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—malignant glioma	8.74e-06	3.26e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	8.73e-06	3.25e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	8.72e-06	3.25e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	8.72e-06	3.25e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	8.7e-06	3.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—malignant glioma	8.69e-06	3.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	8.68e-06	3.23e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—malignant glioma	8.67e-06	3.23e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	8.65e-06	3.22e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	8.64e-06	3.22e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP3—malignant glioma	8.64e-06	3.22e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—malignant glioma	8.63e-06	3.21e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	8.62e-06	3.21e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—malignant glioma	8.62e-06	3.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	8.61e-06	3.21e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	8.59e-06	3.2e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	8.58e-06	3.2e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	8.57e-06	3.19e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	8.56e-06	3.19e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	8.56e-06	3.19e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CG—malignant glioma	8.55e-06	3.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	8.54e-06	3.18e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—malignant glioma	8.53e-06	3.18e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	8.52e-06	3.17e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—malignant glioma	8.52e-06	3.17e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	8.51e-06	3.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP3—malignant glioma	8.5e-06	3.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—malignant glioma	8.49e-06	3.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP3—malignant glioma	8.48e-06	3.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—malignant glioma	8.47e-06	3.16e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—malignant glioma	8.46e-06	3.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP3—malignant glioma	8.46e-06	3.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—malignant glioma	8.44e-06	3.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP3—malignant glioma	8.43e-06	3.14e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	8.43e-06	3.14e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	8.43e-06	3.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—malignant glioma	8.42e-06	3.14e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	8.41e-06	3.13e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	8.4e-06	3.13e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	8.35e-06	3.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP3—malignant glioma	8.35e-06	3.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—malignant glioma	8.34e-06	3.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	8.33e-06	3.1e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	8.31e-06	3.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—malignant glioma	8.31e-06	3.1e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	8.31e-06	3.09e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—malignant glioma	8.28e-06	3.09e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—malignant glioma	8.27e-06	3.08e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—malignant glioma	8.26e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—malignant glioma	8.26e-06	3.07e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—malignant glioma	8.23e-06	3.06e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—malignant glioma	8.2e-06	3.05e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CD—malignant glioma	8.18e-06	3.04e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—malignant glioma	8.17e-06	3.04e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—malignant glioma	8.15e-06	3.04e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—malignant glioma	8.15e-06	3.03e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	8.15e-06	3.03e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—malignant glioma	8.12e-06	3.02e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	8.08e-06	3.01e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	8.08e-06	3.01e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—malignant glioma	8.04e-06	3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—malignant glioma	8.04e-06	2.99e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—malignant glioma	8.02e-06	2.99e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	8e-06	2.98e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—malignant glioma	7.99e-06	2.98e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—malignant glioma	7.99e-06	2.98e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CD—malignant glioma	7.98e-06	2.97e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAT—malignant glioma	7.98e-06	2.97e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—malignant glioma	7.97e-06	2.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—malignant glioma	7.97e-06	2.97e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—malignant glioma	7.96e-06	2.97e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	7.96e-06	2.97e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—malignant glioma	7.96e-06	2.96e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	7.95e-06	2.96e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—malignant glioma	7.95e-06	2.96e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—malignant glioma	7.92e-06	2.95e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—malignant glioma	7.92e-06	2.95e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—malignant glioma	7.89e-06	2.94e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	7.88e-06	2.93e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	7.87e-06	2.93e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—malignant glioma	7.84e-06	2.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	7.82e-06	2.91e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	7.81e-06	2.91e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	7.79e-06	2.9e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	7.79e-06	2.9e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—malignant glioma	7.78e-06	2.9e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—malignant glioma	7.77e-06	2.9e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	7.75e-06	2.89e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	7.74e-06	2.88e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	7.73e-06	2.88e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—malignant glioma	7.72e-06	2.88e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—malignant glioma	7.7e-06	2.87e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—malignant glioma	7.68e-06	2.86e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	7.65e-06	2.85e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—malignant glioma	7.64e-06	2.85e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	7.63e-06	2.84e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	7.59e-06	2.83e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—malignant glioma	7.55e-06	2.81e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NCOR1—malignant glioma	7.53e-06	2.81e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—malignant glioma	7.52e-06	2.8e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—malignant glioma	7.52e-06	2.8e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	7.48e-06	2.79e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	7.48e-06	2.79e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—malignant glioma	7.48e-06	2.78e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—malignant glioma	7.44e-06	2.77e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	7.36e-06	2.74e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—malignant glioma	7.34e-06	2.73e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—malignant glioma	7.33e-06	2.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—malignant glioma	7.32e-06	2.73e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	7.31e-06	2.72e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	7.27e-06	2.71e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	7.27e-06	2.71e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—malignant glioma	7.26e-06	2.7e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—malignant glioma	7.24e-06	2.7e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—malignant glioma	7.24e-06	2.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	7.22e-06	2.69e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—malignant glioma	7.2e-06	2.68e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—malignant glioma	7.2e-06	2.68e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—malignant glioma	7.19e-06	2.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	7.18e-06	2.67e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	7.16e-06	2.67e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	7.15e-06	2.66e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—malignant glioma	7.14e-06	2.66e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—malignant glioma	7.14e-06	2.66e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—malignant glioma	7.13e-06	2.66e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—malignant glioma	7.13e-06	2.65e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—malignant glioma	7.11e-06	2.65e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—malignant glioma	7.1e-06	2.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	7.09e-06	2.64e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	7.08e-06	2.64e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—malignant glioma	7.08e-06	2.64e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	7.06e-06	2.63e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—malignant glioma	7.06e-06	2.63e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—malignant glioma	7.06e-06	2.63e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—malignant glioma	7.01e-06	2.61e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—malignant glioma	7e-06	2.61e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	7e-06	2.61e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—malignant glioma	6.96e-06	2.59e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—malignant glioma	6.89e-06	2.57e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—malignant glioma	6.88e-06	2.56e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	6.87e-06	2.56e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—malignant glioma	6.79e-06	2.53e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	6.76e-06	2.52e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	6.76e-06	2.52e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—malignant glioma	6.75e-06	2.51e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—malignant glioma	6.68e-06	2.49e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—malignant glioma	6.64e-06	2.47e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—malignant glioma	6.62e-06	2.47e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—malignant glioma	6.6e-06	2.46e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—malignant glioma	6.6e-06	2.46e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—malignant glioma	6.58e-06	2.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	6.56e-06	2.44e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—malignant glioma	6.55e-06	2.44e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—malignant glioma	6.54e-06	2.43e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	6.52e-06	2.43e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—malignant glioma	6.52e-06	2.43e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—malignant glioma	6.5e-06	2.42e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—malignant glioma	6.5e-06	2.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	6.5e-06	2.42e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—malignant glioma	6.49e-06	2.42e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—malignant glioma	6.49e-06	2.42e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	6.49e-06	2.42e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—malignant glioma	6.48e-06	2.41e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—malignant glioma	6.46e-06	2.41e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—malignant glioma	6.44e-06	2.4e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—malignant glioma	6.38e-06	2.37e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	6.36e-06	2.37e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—malignant glioma	6.35e-06	2.37e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	6.31e-06	2.35e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—malignant glioma	6.31e-06	2.35e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—malignant glioma	6.28e-06	2.34e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—malignant glioma	6.23e-06	2.32e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	6.21e-06	2.31e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—malignant glioma	6.2e-06	2.31e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—malignant glioma	6.17e-06	2.3e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—malignant glioma	6.16e-06	2.29e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAV1—malignant glioma	6.14e-06	2.29e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—malignant glioma	6.13e-06	2.28e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—malignant glioma	6.13e-06	2.28e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—malignant glioma	6.12e-06	2.28e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—malignant glioma	6.11e-06	2.28e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	6.11e-06	2.28e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—malignant glioma	6.11e-06	2.27e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—malignant glioma	6.1e-06	2.27e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—malignant glioma	6.08e-06	2.27e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—malignant glioma	6.04e-06	2.25e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—malignant glioma	6.02e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—malignant glioma	6.01e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—malignant glioma	6.01e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	6.01e-06	2.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	5.91e-06	2.2e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	5.73e-06	2.13e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—malignant glioma	5.66e-06	2.11e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	5.64e-06	2.1e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	5.62e-06	2.09e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.62e-06	2.09e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	5.61e-06	2.09e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.59e-06	2.08e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	5.59e-06	2.08e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	5.58e-06	2.08e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—malignant glioma	5.54e-06	2.06e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	5.53e-06	2.06e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	5.52e-06	2.06e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	5.52e-06	2.06e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—malignant glioma	5.46e-06	2.03e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—malignant glioma	5.45e-06	2.03e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—malignant glioma	5.44e-06	2.03e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—malignant glioma	5.42e-06	2.02e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—malignant glioma	5.41e-06	2.01e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—malignant glioma	5.4e-06	2.01e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—malignant glioma	5.35e-06	1.99e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—malignant glioma	5.34e-06	1.99e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—malignant glioma	5.33e-06	1.98e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—malignant glioma	5.3e-06	1.97e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	5.16e-06	1.92e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	5.13e-06	1.91e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	5.07e-06	1.89e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—malignant glioma	5.01e-06	1.87e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—malignant glioma	4.96e-06	1.85e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.92e-06	1.83e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—malignant glioma	4.68e-06	1.74e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—malignant glioma	4.6e-06	1.71e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—malignant glioma	4.59e-06	1.71e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—malignant glioma	4.59e-06	1.71e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—malignant glioma	4.58e-06	1.71e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—malignant glioma	4.56e-06	1.7e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—malignant glioma	4.52e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	4.51e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—malignant glioma	4.34e-06	1.62e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.29e-06	1.6e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—malignant glioma	4.25e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—malignant glioma	4.24e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.19e-06	1.56e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—malignant glioma	4e-06	1.49e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—malignant glioma	3.7e-06	1.38e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—malignant glioma	3.55e-06	1.32e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—malignant glioma	3.46e-06	1.29e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—malignant glioma	3.26e-06	1.22e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.61e-06	9.73e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—malignant glioma	2.13e-06	7.95e-06	CbGpPWpGaD
